Anti-Endotoxin Monoclonal Antibody

Gram-negative bacteria produce endotoxins that consist of lipopolysaccharides (LPS) with lipid A functioning as the active site. These components drive bacterial virulence through their pyrogenic and immunogenic properties which activate several human immune responses. During cell death or lysis bacterial cell walls release endotoxins contaminating medical equipment and drug formulations thereby endangering human health.

Creative Diagnostics's developed monoclonal antibodies that attach to endotoxins' conserved core structure demonstrate ideal compatibility with ELISA detection methods.

Mouse Anti-Endotoxin Monoclonal antibody, clone 448.6 (CABT-CS921)

Mouse Anti-Endotoxin Monoclonal antibody, clone 416.7 (CABT-CS922)

Mouse Anti-Endotoxin Monoclonal antibody, clone 224.4 (CABT-CS923)

Mouse Anti-Endotoxin Monoclonal antibody, clone 276.6 (CABT-CS924)

Mouse Anti-Endotoxin Monoclonal antibody, clone 281.4.2 (CABT-CS925)

Mouse Anti-Endotoxin Monoclonal antibody, clone 333.5 (CABT-CS926)

Mouse Anti-Endotoxin Monoclonal antibody, clone 283.6 (CABT-CS927)

Mouse Anti-Endotoxin Monoclonal antibody, clone 556.3 (CABT-CS928)

Mouse Anti-Endotoxin Monoclonal antibody, clone 331.2 (CABT-CS929)

The agents target multiple Gram-negative bacterial species including Klebsiella pneumoniae, Shigella sonnei, Salmonella typhimurium, Serratia marcescens, Proteus vulgaris, Enterobacter aerogenes, Acinetobacter calcoaceticus and Pseudomonas aeruginosa.

Additionally, we offer labeled antibody formats that merge our catalog products with fluorescent dyes and enzyme labels including HRP, biotin, ALP, DyLight®, and R-phycoerythrin (R-PE). Each antibody can be purchased in amounts ranging from 100 μg to 1 g of purified IgG and it passes through rigorous quality control tests to maintain reliable performance while exhibiting high specificity and strong affinity in various experimental conditions.

Can't find the right solutions? Contact our team to get a free consultation.

Request a Quote

Applications of Anti-Endotoxin Monoclonal Antibody in R&D

The Anti-Endotoxin Monoclonal Antibody shows substantial promise across multiple research domains and therapeutic applications.

1. Neutralizing Endotoxin
   The antibody attaches to lipid-A to obstruct its connection with host receptors which results in a reduction of the immune response triggered by endotoxins.
2. Immunological Research
   The system enables researchers to analyze how the immune system responds to endotoxins which deepens our understanding of their function in infection and inflammation.
3. Drug Development
   The research initiative helps identify novel treatments which focus on diseases triggered by endotoxins with an emphasis on sepsis.
4. Vaccine Development
   This tool helps assess how vaccine candidates generate immune reactions to endotoxins.
5. Preclinical Research
   Animal models serve as a testing ground for anti-endotoxin treatments which generate essential data for clinical trial development.

The Anti-Endotoxin Monoclonal Antibody becomes a powerful instrument for your research and therapeutic projects after selection. These antibodies are developed to solve a major problem in infection and inflammation research which will result in new treatment methods and improved scientific understanding.

Advanced immunology drug development and vaccine research require dependable precision which our Anti-Endotoxin Monoclonal Antibody provides. Through its ability to neutralize endotoxin activity researchers can utilize this product as an essential tool to investigate Gram-negative infections and their results.

Choose our product to join forces with us as we advance scientific findings in endotoxin research. If there are any questions or want to see detailed information, just simply Contact Us or Submit an Online Inquiry (click on the product details page and scroll to the bottom) to receive our dedicated support!

Endotoxin Antibodies